Anavex Signs Agreement Allowing Biogen to Test Clinical Stage Drug

Anavex Life Sciences, a clinical stage biopharmaceutical company that develops drugs for treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s and multiple sclerosis, said it signed an agreement under which Biogen (BIIB) will test its leading drug candidate. The company said Biogen will test its Anavex 2-73 drug that’s designed to battle demyelinating diseases such as multiple sclerosis, which requires[Read More…]

by September 28, 2016 0 comments Analyst Briefs, Featured, News, Stocks

TriMas Consolidates Production Facilities

TriMas, a manufacturer of engineered products, said it is closing more factories as part of an ongoing effort to fully utilize existing locations and to better serve customers. Aerospace production in Paris, Arkansas, will be consolidated into the Ottawa, Kansas facility; engineered components activities at two Tulsa, Oklahoma facilities will be consolidated into another existing Tulsa location and packaging in[Read More…]

by September 28, 2016 0 comments Analyst Briefs, News, Stock News, Stocks